Search Orphan Drug Designations and Approvals
-
Generic Name: | Benralizumab |
---|---|
Date Designated: | 11/01/2021 |
Orphan Designation: | Treatment of eosinophilic gastritis (EG) and/or eosinophilic gastroenteritis (EGE) |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 02/07/2025 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
AstraZeneca Pharmaceuticals LP 1800 Concord Pike P.O. Box 8355 Wilmington, Delaware 19803 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-